Essential Medicines Strategic Stockpile Act of 2020
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Oct 1, 2020)
Essential Medicines Strategic Stockpile Act of 2020
This bill requires the Department of Health and Human Services (HHS) to create a pilot program with private entities to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage.
Specifically, HHS must enter into contracts of up to three years for entities to create a six-month stockpile of up to 50 types of such drugs.
The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.
What just happenedOct 1, 2020
Referred to the House Committee on Energy and Commerce.
Who’s behind it
- Introduced in HouseOct 1, 2020
- Oct 1, 2020IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Oct 1, 2020IntroReferralIntro-H
Introduced in House
- Oct 1, 2020IntroReferral1000
Introduced in House